No it doesn't matter as it appears that the target of 18 dogs will not be met.
It also appears that no big pharma company wants to put money into mpl canine trials so if they decide to continue to a phase 3 it will be on their own.
It also looks like no one is interested in the OHD technology either, so it's mnd and now the old carrots being brought out of retirement human cancer and covid to be dangled in front of investors
Ann: Progress update on Phase 1/2 MND interim analysis, page-48
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.010(4.88%) |
Mkt cap ! $104.6M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.5¢ | 20.5¢ | $244.1K | 1.163M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 71981 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 84173 | 3 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |